Atlas Trials

Safety & Efficacy of Sofosbuvir 400mg/Ledipasvir 90mg in the Treatment of Chronic Hepatitis C Adolescents

Clinical trial NCT03343444 · UNKNOWN

Trial details

NCT number
NCT03343444
Sponsor
Egyptian Liver Hospital
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis C Virus Infection, Response to Therapy of
Start date
2017-04-15
Primary completion
2018-11-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.